메뉴 건너뛰기




Volumn 5, Issue 5, 2014, Pages 374-387

Liver-directed therapies in metastatic colorectal cancer

Author keywords

Colorectal cancer (CRC); Hepatectomy; liver metastases; portal vein embolization (PVE); Radiofrequency ablation (RFA)

Indexed keywords

AMINOTRANSFERASE; BEVACIZUMAB; CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; ETHIODIZED OIL; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MACROSALB TC 99M; MICROSPHERE; MICROSPHERE Y 90; OXALIPLATIN; PANITUMUMAB; UNCLASSIFIED DRUG; YTTRIUM 90;

EID: 84995811817     PISSN: 20786891     EISSN: 2219679X     Source Type: Journal    
DOI: 10.3978/j.issn.2078-6891.2014.064     Document Type: Review
Times cited : (59)

References (141)
  • 1
    • 84863707351 scopus 로고    scopus 로고
    • Cancer treatment and survivorship statistics
    • 2012
    • Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012;62:220-41.
    • (2012) CA Cancer J Clin , vol.62 , pp. 220-241
    • Siegel, R.1    DeSantis, C.2    Virgo, K.3
  • 2
    • 70449506641 scopus 로고    scopus 로고
    • New paradigm in the management of liver-only metastases from colorectal cancer
    • Donadon M, Ribero D, Morris-Stiff G, et al. New paradigm in the management of liver-only metastases from colorectal cancer. Gastrointest Cancer Res 2007;1:20-7.
    • (2007) Gastrointest Cancer Res , vol.1 , pp. 20-27
    • Donadon, M.1    Ribero, D.2    Morris-Stiff, G.3
  • 3
    • 33748931490 scopus 로고    scopus 로고
    • Improving resectability of hepatic colorectal metastases: Expert consensus statement
    • Abdalla EK, Adam R, Bilchik AJ, et al. Improving resectability of hepatic colorectal metastases: Expert consensus statement. Ann Surg Oncol 2006;13:1271-80.
    • (2006) Ann Surg Oncol , vol.13 , pp. 1271-1280
    • Abdalla, E.K.1    Adam, R.2    Bilchik, A.J.3
  • 4
    • 20944450851 scopus 로고    scopus 로고
    • Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases
    • 715-22, discussion
    • Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005;241:715-22, discussion 722-4.
    • (2005) Ann Surg , vol.241 , pp. 722-724
    • Pawlik, T.M.1    Scoggins, C.R.2    Zorzi, D.3
  • 5
    • 0025856327 scopus 로고
    • Indicators of prognosis after hepatic resection for colorectal secondaries
    • Scheele J, Stangl R, Altendorf-Hofmann A, et al. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991;110:13-29.
    • (1991) Surgery , vol.110 , pp. 13-29
    • Scheele, J.1    Stangl, R.2    Altendorf-Hofmann, A.3
  • 6
    • 0036104072 scopus 로고    scopus 로고
    • Trends in long-term survival following liver resection for hepatic colorectal metastases
    • Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235:759-66.
    • (2002) Ann Surg , vol.235 , pp. 759-766
    • Choti, M.A.1    Sitzmann, J.V.2    Tiburi, M.F.3
  • 7
    • 0023854339 scopus 로고
    • Resection of the liver for colorectal carcinoma metastases A multi-institutional study of long-term survivors.
    • Hughes KS, Rosenstein RB, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum 1988;31:1-4.
    • (1988) Dis Colon Rectum , vol.31 , pp. 1-4
    • Hughes, K.S.1    Rosenstein, R.B.2    Songhorabodi, S.3
  • 8
    • 0021238871 scopus 로고
    • Resection of hepatic metastases from colorectal cancer
    • Adson MA, van Heerden JA, Adson MH, et al. Resection of hepatic metastases from colorectal cancer. Arch Surg 1984;119:647-51.
    • (1984) Arch Surg , vol.119 , pp. 647-651
    • Adson, M.A.1    van Heerden, J.A.2    Adson, M.H.3
  • 9
    • 0028114794 scopus 로고
    • Experience in hepatic resection for metastatic colorectal cancer: Analysis of clinical and pathologic risk factors
    • 703-10; discussion
    • Gayowski TJ, Iwatsuki S, Madariaga JR, et al. Experience in hepatic resection for metastatic colorectal cancer: Analysis of clinical and pathologic risk factors. Surgery 1994;116:703-10; discussion 710-1.
    • (1994) Surgery , vol.116 , pp. 710-711
    • Gayowski, T.J.1    Iwatsuki, S.2    Madariaga, J.R.3
  • 10
    • 0030958415 scopus 로고    scopus 로고
    • Hepatic resection for metastatic colorectal cancer
    • Jenkins LT, Millikan KW, Bines SD, et al. Hepatic resection for metastatic colorectal cancer. Am Surg 1997;63:605-10.
    • (1997) Am Surg , vol.63 , pp. 605-610
    • Jenkins, L.T.1    Millikan, K.W.2    Bines, S.D.3
  • 11
    • 71149086933 scopus 로고    scopus 로고
    • Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: Results from an international multi-institutional analysis
    • de Jong MC, Mayo SC, Pulitano C, et al. Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: Results from an international multi-institutional analysis. J Gastrointest Surg 2009;13:2141-51.
    • (2009) J Gastrointest Surg , vol.13 , pp. 2141-2151
    • de Jong, M.C.1    Mayo, S.C.2    Pulitano, C.3
  • 12
    • 0033504042 scopus 로고    scopus 로고
    • Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases
    • 309-18; discussion
    • Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999;230:309-18; discussion 318-21.
    • (1999) Ann Surg , vol.230 , pp. 318-321
    • Fong, Y.1    Fortner, J.2    Sun, R.L.3
  • 13
    • 2442704240 scopus 로고    scopus 로고
    • Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases
    • 818-25; discussion
    • Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239:818-25; discussion 825-7.
    • (2004) Ann Surg , vol.239 , pp. 825-827
    • Abdalla, E.K.1    Vauthey, J.N.2    Ellis, L.M.3
  • 14
    • 0030973169 scopus 로고    scopus 로고
    • Hepatic resection for metastatic colorectal cancer results in cure for some patients
    • 505-10; discussion
    • Jamison RL, Donohue JH, Nagorney DM, et al. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 1997;132:505-10; discussion 511.
    • (1997) Arch Surg , vol.132 , pp. 511
    • Jamison, R.L.1    Donohue, J.H.2    Nagorney, D.M.3
  • 15
    • 84890651791 scopus 로고    scopus 로고
    • Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy
    • Fischer C, Melstrom LG, Arnaoutakis D, et al. Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy. JAMA Surg 2013;148:1103-8.
    • (2013) JAMA Surg , vol.148 , pp. 1103-1108
    • Fischer, C.1    Melstrom, L.G.2    Arnaoutakis, D.3
  • 16
    • 84888235220 scopus 로고    scopus 로고
    • Safety and outcomes following resection of colorectal liver metastases in the era of current perioperative chemotherapy
    • Gur I, Diggs BS, Wagner JA, et al. Safety and outcomes following resection of colorectal liver metastases in the era of current perioperative chemotherapy. J Gastrointest Surg 2013;17:2133-42.
    • (2013) J Gastrointest Surg , vol.17 , pp. 2133-2142
    • Gur, I.1    Diggs, B.S.2    Wagner, J.A.3
  • 17
    • 84886719568 scopus 로고    scopus 로고
    • Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): Long-term results of a randomised, controlled, phase 3 trial
    • Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): Long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 2013;14:1208-15.
    • (2013) Lancet Oncol , vol.14 , pp. 1208-1215
    • Nordlinger, B.1    Sorbye, H.2    Glimelius, B.3
  • 18
    • 4344615981 scopus 로고    scopus 로고
    • Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET)
    • 438-47; discussion
    • Fernandez FG, Drebin JA, Linehan DC, et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004;240:438-47; discussion 447-50.
    • (2004) Ann Surg , vol.240 , pp. 447-450
    • Fernandez, F.G.1    Drebin, J.A.2    Linehan, D.C.3
  • 19
    • 0029881854 scopus 로고    scopus 로고
    • Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. association francaise de chirurgie
    • Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. association francaise de chirurgie. Cancer 1996;77:1254-62.
    • (1996) Cancer , vol.77 , pp. 1254-1262
    • Nordlinger, B.1    Guiguet, M.2    Vaillant, J.C.3
  • 20
    • 0034911059 scopus 로고    scopus 로고
    • Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors
    • Bowles BJ, Machi J, Limm WM, et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg 2001;136:864-9.
    • (2001) Arch Surg , vol.136 , pp. 864-869
    • Bowles, B.J.1    Machi, J.2    Limm, W.M.3
  • 21
    • 35648969531 scopus 로고    scopus 로고
    • Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases
    • Malik HZ, Prasad KR, Halazun KJ, et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg 2007;246:806-14.
    • (2007) Ann Surg , vol.246 , pp. 806-814
    • Malik, H.Z.1    Prasad, K.R.2    Halazun, K.J.3
  • 22
    • 84888303677 scopus 로고    scopus 로고
    • Optimizing unresectable colorectal liver metastases for surgery--no limits, any benefits?
    • Gall TM, Frampton AE, Krell J, et al. Optimizing unresectable colorectal liver metastases for surgery--no limits, any benefits? J Gastrointest Surg 2013;17:2185-7.
    • (2013) J Gastrointest Surg , vol.17 , pp. 2185-2187
    • Gall, T.M.1    Frampton, A.E.2    Krell, J.3
  • 23
    • 33646769966 scopus 로고    scopus 로고
    • Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: A critical appraisal of the 1cm rule
    • Hamady ZZ, Cameron IC, Wyatt J, et al. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: A critical appraisal of the 1cm rule. Eur J Surg Oncol 2006;32:557-63.
    • (2006) Eur J Surg Oncol , vol.32 , pp. 557-563
    • Hamady, Z.Z.1    Cameron, I.C.2    Wyatt, J.3
  • 24
    • 73249139329 scopus 로고    scopus 로고
    • 'Close shave' in liver resection for colorectal liver metastases
    • Lordan JT, Karanjia ND. 'Close shave' in liver resection for colorectal liver metastases. Eur J Surg Oncol 2010;36:47-51.
    • (2010) Eur J Surg Oncol , vol.36 , pp. 47-51
    • Lordan, J.T.1    Karanjia, N.D.2
  • 25
    • 34547830898 scopus 로고    scopus 로고
    • Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. evidences from 663 liver resections
    • Figueras J, Burdio F, Ramos E, et al. Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. evidences from 663 liver resections. Ann Oncol 2007;18:1190-5.
    • (2007) Ann Oncol , vol.18 , pp. 1190-1195
    • Figueras, J.1    Burdio, F.2    Ramos, E.3
  • 26
    • 84888295360 scopus 로고    scopus 로고
    • Impact of hepatectomy margin on survival following resection of colorectal metastasis: The role of adjuvant therapy and its effects
    • Mbah NA, Scoggins C, McMasters K, et al. Impact of hepatectomy margin on survival following resection of colorectal metastasis: The role of adjuvant therapy and its effects. Eur J Surg Oncol 2013;39:1394-9.
    • (2013) Eur J Surg Oncol , vol.39 , pp. 1394-1399
    • Mbah, N.A.1    Scoggins, C.2    McMasters, K.3
  • 27
    • 77952093635 scopus 로고    scopus 로고
    • Resection margin and recurrence-free survival after liver resection of colorectal metastases
    • Muratore A, Ribero D, Zimmitti G, et al. Resection margin and recurrence-free survival after liver resection of colorectal metastases. Ann Surg Oncol 2010;17:1324-9.
    • (2010) Ann Surg Oncol , vol.17 , pp. 1324-1329
    • Muratore, A.1    Ribero, D.2    Zimmitti, G.3
  • 28
    • 0034013495 scopus 로고    scopus 로고
    • Standardized measurement of the future liver remnant prior to extended liver resection: Methodology and clinical associations
    • Vauthey JN, Chaoui A, Do KA, et al. Standardized measurement of the future liver remnant prior to extended liver resection: Methodology and clinical associations. Surgery 2000;127:512-9.
    • (2000) Surgery , vol.127 , pp. 512-519
    • Vauthey, J.N.1    Chaoui, A.2    Do, K.A.3
  • 29
    • 11144357293 scopus 로고    scopus 로고
    • Is extended hepatectomy for hepatobiliary malignancy justified?
    • 722-30; discussion
    • Vauthey JN, Pawlik TM, Abdalla EK, et al. Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 2004;239:722-30; discussion 730-2.
    • (2004) Ann Surg , vol.239 , pp. 730-732
    • Vauthey, J.N.1    Pawlik, T.M.2    Abdalla, E.K.3
  • 30
    • 0036269410 scopus 로고    scopus 로고
    • Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization
    • 675-80; discussion
    • Abdalla EK, Barnett CC, Doherty D, et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002;137:675-80; discussion 680-1.
    • (2002) Arch Surg , vol.137 , pp. 680-681
    • Abdalla, E.K.1    Barnett, C.C.2    Doherty, D.3
  • 31
    • 33845602966 scopus 로고    scopus 로고
    • Remnant liver volume to body weight ratio > or =0 5%: A new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver
    • Truant S, Oberlin O, Sergent G, et al. Remnant liver volume to body weight ratio > or =0.5%: A new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J Am Coll Surg 2007;204:22-33.
    • (2007) J Am Coll Surg , vol.204 , pp. 22-33
    • Truant, S.1    Oberlin, O.2    Sergent, G.3
  • 32
    • 79151471645 scopus 로고    scopus 로고
    • Concomitant extrahepatic disease in patients with colorectal liver metastases: When is there a place for surgery?
    • Adam R, de Haas RJ, Wicherts DA, et al. Concomitant extrahepatic disease in patients with colorectal liver metastases: When is there a place for surgery? Ann Surg 2011;253:349-59.
    • (2011) Ann Surg , vol.253 , pp. 349-359
    • Adam, R.1    de Haas, R.J.2    Wicherts, D.A.3
  • 33
    • 79955867194 scopus 로고    scopus 로고
    • Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis
    • Pulitanò C, Bodingbauer M, Aldrighetti L, et al. Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis. Ann Surg Oncol 2011;18:1380-8.
    • (2011) Ann Surg Oncol , vol.18 , pp. 1380-1388
    • Pulitanò, C.1    Bodingbauer, M.2    Aldrighetti, L.3
  • 34
    • 0032791959 scopus 로고    scopus 로고
    • Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
    • Giacchetti S, Itzhaki M, Gruia G, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999;10:663-9.
    • (1999) Ann Oncol , vol.10 , pp. 663-669
    • Giacchetti, S.1    Itzhaki, M.2    Gruia, G.3
  • 35
    • 30944445619 scopus 로고    scopus 로고
    • Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer
    • Masi G, Cupini S, Marcucci L, et al. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol 2006;13:58-65.
    • (2006) Ann Surg Oncol , vol.13 , pp. 58-65
    • Masi, G.1    Cupini, S.2    Marcucci, L.3
  • 36
    • 84864144885 scopus 로고    scopus 로고
    • Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases--a systematic review
    • Chua TC, Saxena A, Liauw W, et al. Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases--a systematic review. Eur J Cancer 2012;48:1757-65.
    • (2012) Eur J Cancer , vol.48 , pp. 1757-1765
    • Chua, T.C.1    Saxena, A.2    Liauw, W.3
  • 37
    • 73949137339 scopus 로고    scopus 로고
    • Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: Retrospective analysis of 523 patients from a multicentric french study
    • Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: Retrospective analysis of 523 patients from a multicentric french study. J Clin Oncol 2010;28:63-8.
    • (2010) J Clin Oncol , vol.28 , pp. 63-68
    • Elias, D.1    Gilly, F.2    Boutitie, F.3
  • 38
    • 84872201863 scopus 로고    scopus 로고
    • Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements
    • (Oxford)
    • Abdalla EK, Bauer TW, Chun YS, et al. Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. HPB (Oxford) 2013;15:119-30.
    • (2013) HPB , vol.15 , pp. 119-130
    • Abdalla, E.K.1    Bauer, T.W.2    Chun, Y.S.3
  • 39
    • 84875366445 scopus 로고    scopus 로고
    • Surgical management of patients with synchronous colorectal liver metastasis: A multicenter international analysis
    • 707-16; discussion
    • Mayo SC, Pulitano C, Marques H, et al. Surgical management of patients with synchronous colorectal liver metastasis: A multicenter international analysis. J Am Coll Surg 2013;216:707-16; discussion 716-8.
    • (2013) J Am Coll Surg , vol.216 , pp. 716-718
    • Mayo, S.C.1    Pulitano, C.2    Marques, H.3
  • 40
    • 79951721040 scopus 로고    scopus 로고
    • Simultaneous vs. staged resection for synchronous colorectal liver metastases: A metaanalysis
    • Chen J, Li Q, Wang C, et al. Simultaneous vs. staged resection for synchronous colorectal liver metastases: A metaanalysis. Int J Colorectal Dis 2011;26:191-9.
    • (2011) Int J Colorectal Dis , vol.26 , pp. 191-199
    • Chen, J.1    Li, Q.2    Wang, C.3
  • 41
    • 64949168595 scopus 로고    scopus 로고
    • Simultaneous versus staged resection for synchronous colorectal cancer liver metastases
    • 842-50; discussion
    • Martin RC 2nd, Augenstein V, Reuter NP, et al. Simultaneous versus staged resection for synchronous colorectal cancer liver metastases. J Am Coll Surg. 2009;208:842-50; discussion 850-2.
    • (2009) J Am Coll Surg , vol.208 , pp. 850-852
    • Martin, R.C.1    Augenstein, V.2    Reuter, N.P.3
  • 42
    • 77954958591 scopus 로고    scopus 로고
    • Impact of resection for primary colorectal cancer on outcomes in patients with synchronous colorectal liver metastases
    • Huh JW, Cho CK, Kim HR, et al. Impact of resection for primary colorectal cancer on outcomes in patients with synchronous colorectal liver metastases. J Gastrointest Surg 2010;14:1258-64.
    • (2010) J Gastrointest Surg , vol.14 , pp. 1258-1264
    • Huh, J.W.1    Cho, C.K.2    Kim, H.R.3
  • 43
    • 4644320061 scopus 로고    scopus 로고
    • Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival
    • 644-57; discussion
    • Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival. Ann Surg 2004;240:644-57; discussion 657-8.
    • (2004) Ann Surg , vol.240 , pp. 657-658
    • Adam, R.1    Delvart, V.2    Pascal, G.3
  • 44
    • 2642541197 scopus 로고    scopus 로고
    • Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients
    • Pozzo C, Basso M, Cassano A, et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 2004;15:933-9.
    • (2004) Ann Oncol , vol.15 , pp. 933-939
    • Pozzo, C.1    Basso, M.2    Cassano, A.3
  • 45
    • 84892593223 scopus 로고    scopus 로고
    • Chemotherapy-associated liver injury and its influence on outcome after resection of colorectal liver metastases
    • Reissfelder C, Brand K, Sobiegalla J, et al. Chemotherapy-associated liver injury and its influence on outcome after resection of colorectal liver metastases. Surgery 2014;155:245-54.
    • (2014) Surgery , vol.155 , pp. 245-254
    • Reissfelder, C.1    Brand, K.2    Sobiegalla, J.3
  • 46
    • 84876484196 scopus 로고    scopus 로고
    • Chemotherapy-associated liver injury in patients with colorectal liver metastases: A systematic review and meta-analysis
    • Robinson SM, Wilson CH, Burt AD, et al. Chemotherapy-associated liver injury in patients with colorectal liver metastases: A systematic review and meta-analysis. Ann Surg Oncol 2012;19:4287-99.
    • (2012) Ann Surg Oncol , vol.19 , pp. 4287-4299
    • Robinson, S.M.1    Wilson, C.H.2    Burt, A.D.3
  • 47
    • 33646457231 scopus 로고    scopus 로고
    • Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
    • Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24:2065-72.
    • (2006) J Clin Oncol , vol.24 , pp. 2065-2072
    • Vauthey, J.N.1    Pawlik, T.M.2    Ribero, D.3
  • 48
    • 37549068554 scopus 로고    scopus 로고
    • Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy
    • Nakano H, Oussoultzoglou E, Rosso E, et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 2008;247:118-24.
    • (2008) Ann Surg , vol.247 , pp. 118-124
    • Nakano, H.1    Oussoultzoglou, E.2    Rosso, E.3
  • 49
    • 40749149728 scopus 로고    scopus 로고
    • Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC intergroup trial 40983): A randomised controlled trial
    • Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC intergroup trial 40983): A randomised controlled trial. Lancet 2008;371:1007-16.
    • (2008) Lancet , vol.371 , pp. 1007-1016
    • Nordlinger, B.1    Sorbye, H.2    Glimelius, B.3
  • 50
    • 30144435398 scopus 로고    scopus 로고
    • Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases
    • Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006;243:1-7.
    • (2006) Ann Surg , vol.243 , pp. 1-7
    • Karoui, M.1    Penna, C.2    Amin-Hashem, M.3
  • 51
    • 58549090953 scopus 로고    scopus 로고
    • Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases
    • Scoggins CR, Campbell ML, Landry CS, et al. Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. Ann Surg Oncol 2009;16:35-41.
    • (2009) Ann Surg Oncol , vol.16 , pp. 35-41
    • Scoggins, C.R.1    Campbell, M.L.2    Landry, C.S.3
  • 52
    • 55949084563 scopus 로고    scopus 로고
    • Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases
    • Kesmodel SB, Ellis LM, Lin E, et al. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol 2008;26:5254-60.
    • (2008) J Clin Oncol , vol.26 , pp. 5254-5260
    • Kesmodel, S.B.1    Ellis, L.M.2    Lin, E.3
  • 53
    • 79251504595 scopus 로고    scopus 로고
    • Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases
    • Wicherts DA, de Haas RJ, Sebagh M, et al. Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases. Br J Surg 2011;98:399-407.
    • (2011) Br J Surg , vol.98 , pp. 399-407
    • Wicherts, D.A.1    de Haas, R.J.2    Sebagh, M.3
  • 54
    • 78349300856 scopus 로고    scopus 로고
    • Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases?
    • Adam R, Bhangui P, Poston G, et al. Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Ann Surg 2010;252:774-87.
    • (2010) Ann Surg , vol.252 , pp. 774-787
    • Adam, R.1    Bhangui, P.2    Poston, G.3
  • 55
    • 84907020985 scopus 로고    scopus 로고
    • Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases
    • Zhu D, Zhong Y, Wei Y, et al. Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases. PLoS One 2014;9:e86543.
    • (2014) PLoS One , vol.9 , pp. e86543
    • Zhu, D.1    Zhong, Y.2    Wei, Y.3
  • 56
    • 36348992494 scopus 로고    scopus 로고
    • A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: A case-controlled study
    • Malik HZ, Farid S, Al-Mukthar A, et al. A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: A case-controlled study. Ann Surg Oncol 2007;14:3519-26.
    • (2007) Ann Surg Oncol , vol.14 , pp. 3519-3526
    • Malik, H.Z.1    Farid, S.2    Al-Mukthar, A.3
  • 57
    • 67649210364 scopus 로고    scopus 로고
    • Timing of multimodality therapy for resectable synchronous colorectal liver metastases: A retrospective multi-institutional analysis
    • Reddy SK, Zorzi D, Lum YW, et al. Timing of multimodality therapy for resectable synchronous colorectal liver metastases: A retrospective multi-institutional analysis. Ann Surg Oncol 2009;16:1809-19.
    • (2009) Ann Surg Oncol , vol.16 , pp. 1809-1819
    • Reddy, S.K.1    Zorzi, D.2    Lum, Y.W.3
  • 58
    • 66149155832 scopus 로고    scopus 로고
    • Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: Recommendations from an expert panel
    • Nordlinger B, Van Cutsem E, Gruenberger T, et al. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: Recommendations from an expert panel. Ann Oncol 2009;20:985-92.
    • (2009) Ann Oncol , vol.20 , pp. 985-992
    • Nordlinger, B.1    Van Cutsem, E.2    Gruenberger, T.3
  • 59
    • 46949096368 scopus 로고    scopus 로고
    • Liver regeneration and the atrophy-hypertrophy complex
    • Kim RD, Kim JS, Watanabe G, et al. Liver regeneration and the atrophy-hypertrophy complex. Semin Intervent Radiol 2008;25:92-103.
    • (2008) Semin Intervent Radiol , vol.25 , pp. 92-103
    • Kim, R.D.1    Kim, J.S.2    Watanabe, G.3
  • 60
    • 0035130470 scopus 로고    scopus 로고
    • Portal vein embolization: Rationale, technique and future prospects
    • Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: Rationale, technique and future prospects. Br J Surg 2001;88:165-75.
    • (2001) Br J Surg , vol.88 , pp. 165-175
    • Abdalla, E.K.1    Hicks, M.E.2    Vauthey, J.N.3
  • 61
    • 84862738925 scopus 로고    scopus 로고
    • Role of portal vein embolization in liver surgery: single centre experience in sixty-two patients
    • Ratti F, Soldati C, Catena M, et al. Role of portal vein embolization in liver surgery: single centre experience in sixty-two patients. Updates Surg 2010;62:153-9.
    • (2010) Updates Surg , vol.62 , pp. 153-159
    • Ratti, F.1    Soldati, C.2    Catena, M.3
  • 62
    • 36349022638 scopus 로고    scopus 로고
    • Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome
    • Ribero D, Abdalla EK, Madoff DC, et al. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 2007;94:1386-94.
    • (2007) Br J Surg , vol.94 , pp. 1386-1394
    • Ribero, D.1    Abdalla, E.K.2    Madoff, D.C.3
  • 63
    • 37549026473 scopus 로고    scopus 로고
    • Preoperative portal vein embolization for major liver resection: A meta-analysis
    • Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: A meta-analysis. Ann Surg 2008;247:49-57.
    • (2008) Ann Surg , vol.247 , pp. 49-57
    • Abulkhir, A.1    Limongelli, P.2    Healey, A.J.3
  • 64
    • 0030052596 scopus 로고    scopus 로고
    • Changes in hepatic lobar function after right portal vein embolization. an appraisal by biliary indocyanine green excretion
    • Uesaka K, Nimura Y, Nagino M. Changes in hepatic lobar function after right portal vein embolization. an appraisal by biliary indocyanine green excretion. Ann Surg 1996;223:77-83.
    • (1996) Ann Surg , vol.223 , pp. 77-83
    • Uesaka, K.1    Nimura, Y.2    Nagino, M.3
  • 65
    • 0038441627 scopus 로고    scopus 로고
    • Evaluation of preoperative portal embolization for safe hepatectomy, with special reference to assessment of nonembolized lobe function with 99mTc-GSA SPECT scintigraphy
    • Hirai I, Kimura W, Fuse A, et al. Evaluation of preoperative portal embolization for safe hepatectomy, with special reference to assessment of nonembolized lobe function with 99mTc-GSA SPECT scintigraphy. Surgery 2003;133:495-506.
    • (2003) Surgery , vol.133 , pp. 495-506
    • Hirai, I.1    Kimura, W.2    Fuse, A.3
  • 66
    • 0037380439 scopus 로고    scopus 로고
    • Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: Safety and effectiveness--study in 26 patients
    • Madoff DC, Hicks ME, Abdalla EK, et al. Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: Safety and effectiveness--study in 26 patients. Radiology 2003;227:251-60.
    • (2003) Radiology , vol.227 , pp. 251-260
    • Madoff, D.C.1    Hicks, M.E.2    Abdalla, E.K.3
  • 67
    • 77449111760 scopus 로고    scopus 로고
    • Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases
    • Wicherts DA, de Haas RJ, Andreani P, et al. Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg 2010;97:240-50.
    • (2010) Br J Surg , vol.97 , pp. 240-250
    • Wicherts, D.A.1    de Haas, R.J.2    Andreani, P.3
  • 68
    • 0034126372 scopus 로고    scopus 로고
    • Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization
    • Azoulay D, Castaing D, Smail A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000;231:480-6.
    • (2000) Ann Surg , vol.231 , pp. 480-486
    • Azoulay, D.1    Castaing, D.2    Smail, A.3
  • 69
    • 84887842622 scopus 로고    scopus 로고
    • Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival
    • Shindoh J, Tzeng CW, Aloia TA, et al. Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival. Br J Surg 2013;100:1777-83.
    • (2013) Br J Surg , vol.100 , pp. 1777-1783
    • Shindoh, J.1    Tzeng, C.W.2    Aloia, T.A.3
  • 70
    • 0033011648 scopus 로고    scopus 로고
    • During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma
    • Elias D, De Baere T, Roche A, et al. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 1999;86:784-8.
    • (1999) Br J Surg , vol.86 , pp. 784-788
    • Elias, D.1    De Baere, T.2    Roche, A.3
  • 71
    • 84861814838 scopus 로고    scopus 로고
    • Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases
    • Simoneau E, Aljiffry M, Salman A, et al. Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases. HPB (Oxford) 2012;14:461-8.
    • (2012) HPB (Oxford) , vol.14 , pp. 461-468
    • Simoneau, E.1    Aljiffry, M.2    Salman, A.3
  • 72
    • 70350406417 scopus 로고    scopus 로고
    • Portal vein embolization prior to extensive resection for colorectal liver metastases
    • Pamecha V, Davidson B. Portal vein embolization prior to extensive resection for colorectal liver metastases. Ann Surg Oncol 2009;16:3214.
    • (2009) Ann Surg Oncol , vol.16 , pp. 3214
    • Pamecha, V.1    Davidson, B.2
  • 73
    • 42249100008 scopus 로고    scopus 로고
    • Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases
    • Covey AM, Brown KT, Jarnagin WR, et al. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg 2008;247:451-5.
    • (2008) Ann Surg , vol.247 , pp. 451-455
    • Covey, A.M.1    Brown, K.T.2    Jarnagin, W.R.3
  • 74
    • 79952753550 scopus 로고    scopus 로고
    • High survival rate after two-stage resection of advanced colorectal liver metastases: Response-based selection and complete resection define outcome
    • Brouquet A, Abdalla EK, Kopetz S, et al. High survival rate after two-stage resection of advanced colorectal liver metastases: Response-based selection and complete resection define outcome. J Clin Oncol 2011;29:1083-90.
    • (2011) J Clin Oncol , vol.29 , pp. 1083-1090
    • Brouquet, A.1    Abdalla, E.K.2    Kopetz, S.3
  • 75
    • 34250821875 scopus 로고    scopus 로고
    • Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases
    • Adam R, Miller R, Pitombo M, et al. Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases. Surg Oncol Clin N Am 2007;16:525- 36, viii.
    • (2007) Surg Oncol Clin N Am , vol.16
    • Adam, R.1    Miller, R.2    Pitombo, M.3
  • 76
    • 10044266415 scopus 로고    scopus 로고
    • A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases
    • 1037-49; discussion
    • Jaeck D, Oussoultzoglou E, Rosso E, et al. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 2004;240:1037-49; discussion 1049-51.
    • (2004) Ann Surg , vol.240 , pp. 1049-1051
    • Jaeck, D.1    Oussoultzoglou, E.2    Rosso, E.3
  • 77
    • 80051553000 scopus 로고    scopus 로고
    • Two-stage resection for bilobar colorectal liver metastases: R0 resection is the key
    • Tsim N, Healey AJ, Frampton AE, et al. Two-stage resection for bilobar colorectal liver metastases: R0 resection is the key. Ann Surg Oncol 2011;18:1939-46.
    • (2011) Ann Surg Oncol , vol.18 , pp. 1939-1946
    • Tsim, N.1    Healey, A.J.2    Frampton, A.E.3
  • 78
    • 84857652570 scopus 로고    scopus 로고
    • Playing Play-Doh to prevent postoperative liver failure: the "ALPPS" approach
    • de Santibañes E, Clavien PA. Playing Play-Doh to prevent postoperative liver failure: the "ALPPS" approach. Ann Surg 2012;255:415-7.
    • (2012) Ann Surg , vol.255 , pp. 415-417
    • de Santibañes, E.1    Clavien, P.A.2
  • 79
    • 84857656174 scopus 로고    scopus 로고
    • Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings
    • Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 2012;255:405-14.
    • (2012) Ann Surg , vol.255 , pp. 405-414
    • Schnitzbauer, A.A.1    Lang, S.A.2    Goessmann, H.3
  • 80
    • 84872183133 scopus 로고    scopus 로고
    • In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection
    • Knoefel WT, Gabor I, Rehders A, et al. In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. Br J Surg 2013;100:388-94.
    • (2013) Br J Surg , vol.100 , pp. 388-394
    • Knoefel, W.T.1    Gabor, I.2    Rehders, A.3
  • 81
    • 84897595417 scopus 로고    scopus 로고
    • Defining indications to ALPPS procedure: technical aspects and open issues
    • Ratti F, Cipriani F, Gagliano A, et al. Defining indications to ALPPS procedure: technical aspects and open issues. Updates Surg 2014;66:41-9.
    • (2014) Updates Surg , vol.66 , pp. 41-49
    • Ratti, F.1    Cipriani, F.2    Gagliano, A.3
  • 82
    • 84876121587 scopus 로고    scopus 로고
    • ALPPS in right trisectionectomy: A safe procedure to avoid postoperative liver failure?
    • Li J, Girotti P, Konigsrainer I, et al. ALPPS in right trisectionectomy: A safe procedure to avoid postoperative liver failure? J Gastrointest Surg 2013;17:956-61.
    • (2013) J Gastrointest Surg , vol.17 , pp. 956-961
    • Li, J.1    Girotti, P.2    Konigsrainer, I.3
  • 83
    • 84875053617 scopus 로고    scopus 로고
    • Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): Tips and tricks
    • Alvarez FA, Ardiles V, Sanchez Claria R, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): Tips and tricks. J Gastrointest Surg 2013;17:814-21.
    • (2013) J Gastrointest Surg , vol.17 , pp. 814-821
    • Alvarez, F.A.1    Ardiles, V.2    Sanchez Claria, R.3
  • 84
    • 34247465907 scopus 로고    scopus 로고
    • Hepatic insufficiency and mortality in 1 059 noncirrhotic patients undergoing major hepatectomy.
    • 854-62; discussion
    • Mullen JT, Ribero D, Reddy SK, et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 2007;204:854-62; discussion 862-4.
    • (2007) J Am Coll Surg , vol.204 , pp. 862-864
    • Mullen, J.T.1    Ribero, D.2    Reddy, S.K.3
  • 85
    • 70349527854 scopus 로고    scopus 로고
    • Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database
    • Aloia TA, Fahy BN, Fischer CP, et al. Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database. HPB (Oxford) 2009;11:510-5.
    • (2009) HPB (Oxford) , vol.11 , pp. 510-515
    • Aloia, T.A.1    Fahy, B.N.2    Fischer, C.P.3
  • 86
    • 70349671217 scopus 로고    scopus 로고
    • Three hundred and one consecutive extended right hepatectomies: Evaluation of outcome based on systematic liver volumetry
    • Kishi Y, Abdalla EK, Chun YS, et al. Three hundred and one consecutive extended right hepatectomies: Evaluation of outcome based on systematic liver volumetry. Ann Surg 2009;250:540-8.
    • (2009) Ann Surg , vol.250 , pp. 540-548
    • Kishi, Y.1    Abdalla, E.K.2    Chun, Y.S.3
  • 88
    • 80051551802 scopus 로고    scopus 로고
    • Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases
    • Hammill CW, Billingsley KG, Cassera MA, et al. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases. Ann Surg Oncol 2011;18:1947-54.
    • (2011) Ann Surg Oncol , vol.18 , pp. 1947-1954
    • Hammill, C.W.1    Billingsley, K.G.2    Cassera, M.A.3
  • 89
    • 39749194351 scopus 로고    scopus 로고
    • Thermal ablation of hepatic malignancy: Useful but still not optimal
    • Nicholl MB, Bilchik AJ. Thermal ablation of hepatic malignancy: Useful but still not optimal. Eur J Surg Oncol 2008;34:318-23.
    • (2008) Eur J Surg Oncol , vol.34 , pp. 318-323
    • Nicholl, M.B.1    Bilchik, A.J.2
  • 90
    • 84896736439 scopus 로고    scopus 로고
    • Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. analysis of the european organisation for research and treatment of cancer 40004 and 40983
    • Tanis E, Nordlinger B, Mauer M, et al. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. analysis of the european organisation for research and treatment of cancer #40004 and #40983. Eur J Cancer 2014;50:912-9.
    • (2014) Eur J Cancer , vol.50 , pp. 912-919
    • Tanis, E.1    Nordlinger, B.2    Mauer, M.3
  • 91
    • 66949119654 scopus 로고    scopus 로고
    • A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases
    • Stang A, Fischbach R, Teichmann W, et al. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer 2009;45:1748-56.
    • (2009) Eur J Cancer , vol.45 , pp. 1748-1756
    • Stang, A.1    Fischbach, R.2    Teichmann, W.3
  • 92
    • 1542751065 scopus 로고    scopus 로고
    • Combined resection and radiofrequency ablation for advanced hepatic malignancies: Results in 172 patients
    • Pawlik TM, Izzo F, Cohen DS, et al. Combined resection and radiofrequency ablation for advanced hepatic malignancies: Results in 172 patients. Ann Surg Oncol 2003;10:1059-69.
    • (2003) Ann Surg Oncol , vol.10 , pp. 1059-1069
    • Pawlik, T.M.1    Izzo, F.2    Cohen, D.S.3
  • 93
    • 34748874664 scopus 로고    scopus 로고
    • Survival after radiofrequency ablation of colorectal liver metastases: 10- year experience
    • 559-65; discussion
    • Siperstein AE, Berber E, Ballem N, et al. Survival after radiofrequency ablation of colorectal liver metastases: 10- year experience. Ann Surg 2007;246:559-65; discussion 565-7.
    • (2007) Ann Surg , vol.246 , pp. 565-567
    • Siperstein, A.E.1    Berber, E.2    Ballem, N.3
  • 94
    • 51649112360 scopus 로고    scopus 로고
    • Radiofrequency ablation of colorectal liver metastases: Small size favorably predicts technique effectiveness and survival
    • Veltri A, Sacchetto P, Tosetti I, et al. Radiofrequency ablation of colorectal liver metastases: Small size favorably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol 2008;31:948-56.
    • (2008) Cardiovasc Intervent Radiol , vol.31 , pp. 948-956
    • Veltri, A.1    Sacchetto, P.2    Tosetti, I.3
  • 95
    • 0033835017 scopus 로고    scopus 로고
    • Radiofrequency ablation of 231 unresectable hepatic tumors: Indications, limitations, and complications
    • Wood TF, Rose DM, Chung M, et al. Radiofrequency ablation of 231 unresectable hepatic tumors: Indications, limitations, and complications. Ann Surg Oncol 2000;7:593-600.
    • (2000) Ann Surg Oncol , vol.7 , pp. 593-600
    • Wood, T.F.1    Rose, D.M.2    Chung, M.3
  • 96
    • 38149028468 scopus 로고    scopus 로고
    • Comparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastases
    • Leblanc F, Fonck M, Brunet R, et al. Comparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastases. Eur J Surg Oncol 2008;34:185-90.
    • (2008) Eur J Surg Oncol , vol.34 , pp. 185-190
    • Leblanc, F.1    Fonck, M.2    Brunet, R.3
  • 97
    • 33645849087 scopus 로고    scopus 로고
    • Solitary colorectal liver metastasis: Resection determines outcome
    • 460-6; discussion
    • Aloia TA, Vauthey JN, Loyer EM, et al. Solitary colorectal liver metastasis: Resection determines outcome. Arch Surg 2006;141:460-6; discussion 466-7.
    • (2006) Arch Surg , vol.141 , pp. 466-467
    • Aloia, T.A.1    Vauthey, J.N.2    Loyer, E.M.3
  • 98
    • 0142216191 scopus 로고    scopus 로고
    • Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases
    • Oshowo A, Gillams A, Harrison E, et al. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 2003;90:1240-43.
    • (2003) Br J Surg , vol.90 , pp. 1240-1243
    • Oshowo, A.1    Gillams, A.2    Harrison, E.3
  • 99
    • 84864129583 scopus 로고    scopus 로고
    • Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: A randomized EORTC intergroup phase II study (EORTC 40004)
    • Ruers T, Punt C, Van Coevorden F, et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: A randomized EORTC intergroup phase II study (EORTC 40004). Ann Oncol 2012;23:2619-26.
    • (2012) Ann Oncol , vol.23 , pp. 2619-2626
    • Ruers, T.1    Punt, C.2    Van Coevorden, F.3
  • 100
    • 33846337181 scopus 로고    scopus 로고
    • Radiofrequency ablation permits an effective treatment for colorectal liver metastasis
    • Abitabile P, Hartl U, Lange J, et al. Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. Eur J Surg Oncol 2007;33:67-71.
    • (2007) Eur J Surg Oncol , vol.33 , pp. 67-71
    • Abitabile, P.1    Hartl, U.2    Lange, J.3
  • 101
    • 0034821968 scopus 로고    scopus 로고
    • Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: Long-term results in 117 patients
    • Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: Long-term results in 117 patients. Radiology 2001;221:159-66.
    • (2001) Radiology , vol.221 , pp. 159-166
    • Solbiati, L.1    Livraghi, T.2    Goldberg, S.N.3
  • 102
    • 34247552270 scopus 로고    scopus 로고
    • Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis
    • White RR, Avital I, Sofocleous CT, et al. Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis. J Gastrointest Surg 2007;11:256-63.
    • (2007) J Gastrointest Surg , vol.11 , pp. 256-263
    • White, R.R.1    Avital, I.2    Sofocleous, C.T.3
  • 103
    • 66149137560 scopus 로고    scopus 로고
    • Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases
    • Hur H, Ko YT, Min BS, et al. Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg 2009;197:728-36.
    • (2009) Am J Surg , vol.197 , pp. 728-736
    • Hur, H.1    Ko, Y.T.2    Min, B.S.3
  • 104
    • 38049152698 scopus 로고    scopus 로고
    • Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery
    • Park IJ, Kim HC, Yu CS, et al. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol 2008;15:227-32.
    • (2008) Ann Surg Oncol , vol.15 , pp. 227-232
    • Park, I.J.1    Kim, H.C.2    Yu, C.S.3
  • 105
    • 33750736068 scopus 로고    scopus 로고
    • Radiofrequency ablation of hepatic metastases from colorectal cancer: Are newer generation probes better?
    • Ahmad A, Chen SL, Kavanagh MA, et al. Radiofrequency ablation of hepatic metastases from colorectal cancer: Are newer generation probes better? Am Surg 2006;72:875-9.
    • (2006) Am Surg , vol.72 , pp. 875-879
    • Ahmad, A.1    Chen, S.L.2    Kavanagh, M.A.3
  • 106
    • 84858075200 scopus 로고    scopus 로고
    • Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection
    • Evrard S, Rivoire M, Arnaud J-, et al. Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection. Br J Surg 2012;99:558-65.
    • (2012) Br J Surg , vol.99 , pp. 558-565
    • Evrard, S.1    Rivoire, M.2    Arnaud, J.3
  • 107
    • 85019240525 scopus 로고    scopus 로고
    • Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience
    • [Epub ahead of print]
    • Stättner S, Primavesi F, Yip VS, et al. Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience. Surg Today 2014. [Epub ahead of print].
    • (2014) Surg Today
    • Stättner, S.1    Primavesi, F.2    Yip, V.S.3
  • 108
    • 84880634026 scopus 로고    scopus 로고
    • Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases
    • Karanicolas PJ, Jarnagin WR, Gonen M, et al. Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. JAMA Surg 2013;148:597-601.
    • (2013) JAMA Surg , vol.148 , pp. 597-601
    • Karanicolas, P.J.1    Jarnagin, W.R.2    Gonen, M.3
  • 109
    • 47949117206 scopus 로고    scopus 로고
    • Hepatic microwave ablation: A review of the histological changes following thermal damage
    • Gravante G, Ong SL, Metcalfe MS, et al. Hepatic microwave ablation: A review of the histological changes following thermal damage. Liver Int 2008;28:911-21.
    • (2008) Liver Int , vol.28 , pp. 911-921
    • Gravante, G.1    Ong, S.L.2    Metcalfe, M.S.3
  • 110
    • 0031788993 scopus 로고    scopus 로고
    • A theoretical comparison of energy sources--microwave, ultrasound and laser--for interstitial thermal therapy
    • Skinner MG, Iizuka MN, Kolios MC, et al. A theoretical comparison of energy sources--microwave, ultrasound and laser--for interstitial thermal therapy. Phys Med Biol 1998;43:3535-47.
    • (1998) Phys Med Biol , vol.43 , pp. 3535-3547
    • Skinner, M.G.1    Iizuka, M.N.2    Kolios, M.C.3
  • 111
    • 77953492392 scopus 로고    scopus 로고
    • Microwaves create larger ablations than radiofrequency when controlled for power in ex vivo tissue
    • Andreano A, Huang Y, Meloni MF, et al. Microwaves create larger ablations than radiofrequency when controlled for power in ex vivo tissue. Med Phys 2010;37:2967-73.
    • (2010) Med Phys , vol.37 , pp. 2967-2973
    • Andreano, A.1    Huang, Y.2    Meloni, M.F.3
  • 112
    • 84875226179 scopus 로고    scopus 로고
    • A comparison of direct heating during radiofrequency and microwave ablation in ex vivo liver
    • Andreano A, Brace CL. A comparison of direct heating during radiofrequency and microwave ablation in ex vivo liver. Cardiovasc Intervent Radiol 2013;36:505-11.
    • (2013) Cardiovasc Intervent Radiol , vol.36 , pp. 505-511
    • Andreano, A.1    Brace, C.L.2
  • 113
    • 59149084079 scopus 로고    scopus 로고
    • Ultrasound monitoring of a novel microwave ablation (MWA) device in porcine liver: Lessons learned and phenomena observed on ablative effects near major intrahepatic vessels
    • Garrean S, Hering J, Saied A, et al. Ultrasound monitoring of a novel microwave ablation (MWA) device in porcine liver: Lessons learned and phenomena observed on ablative effects near major intrahepatic vessels. J Gastrointest Surg 2009;13:334-40.
    • (2009) J Gastrointest Surg , vol.13 , pp. 334-340
    • Garrean, S.1    Hering, J.2    Saied, A.3
  • 114
    • 61649096419 scopus 로고    scopus 로고
    • A comparative histological evaluation of the ablations produced by microwave, cryotherapy and radiofrequency in the liver
    • Bhardwaj N, Strickland AD, Ahmad F, et al. A comparative histological evaluation of the ablations produced by microwave, cryotherapy and radiofrequency in the liver. Pathology 2009;41:168-72.
    • (2009) Pathology , vol.41 , pp. 168-172
    • Bhardwaj, N.1    Strickland, A.D.2    Ahmad, F.3
  • 115
    • 84858208775 scopus 로고    scopus 로고
    • Microwave ablation of the liver: A description of lesion evolution over time and an investigation of the heat sink effect
    • Bhardwaj N, Dormer J, Ahmad F, et al. Microwave ablation of the liver: A description of lesion evolution over time and an investigation of the heat sink effect. Pathology 2011;43:725-31.
    • (2011) Pathology , vol.43 , pp. 725-731
    • Bhardwaj, N.1    Dormer, J.2    Ahmad, F.3
  • 116
    • 84900873256 scopus 로고    scopus 로고
    • Microwave ablation for hepatic malignancies: a multiinstitutional analysis
    • Groeschl RT, Pilgrim CH, Hanna EM, et al. Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg 2014;259:1195-200.
    • (2014) Ann Surg , vol.259 , pp. 1195-1200
    • Groeschl, R.T.1    Pilgrim, C.H.2    Hanna, E.M.3
  • 117
    • 0034088535 scopus 로고    scopus 로고
    • Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: A proposed algorithm
    • 657-62; discussion
    • Bilchik AJ, Wood TF, Allegra D, et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: A proposed algorithm. Arch Surg 2000;135:657-62; discussion 662-4.
    • (2000) Arch Surg , vol.135 , pp. 662-664
    • Bilchik, A.J.1    Wood, T.F.2    Allegra, D.3
  • 118
    • 0033387726 scopus 로고    scopus 로고
    • Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies
    • Pearson AS, Izzo F, Fleming RY, et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999;178:592-9.
    • (1999) Am J Surg , vol.178 , pp. 592-599
    • Pearson, A.S.1    Izzo, F.2    Fleming, R.Y.3
  • 119
    • 78651053472 scopus 로고
    • Studies on the blood supply of tumors in man III. Vascular patterns of the liver by hepatic arteriography in vivo
    • Bierman HR, Byron RL JR, Kelley KH, et al. Studies on the blood supply of tumors in man. III. Vascular patterns of the liver by hepatic arteriography in vivo. J Natl Cancer Inst 1951;12:107-31.
    • (1951) J Natl Cancer Inst , vol.12 , pp. 107-131
    • Bierman, H.R.1    Byron, R.L.J.R.2    Kelley, K.H.3
  • 120
    • 85123039270 scopus 로고    scopus 로고
    • Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: Expert consensus statement
    • Karanicolas PJ, Metrakos P, Chan K, et al. Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: Expert consensus statement. Curr Oncol 2014;21:e129-36.
    • (2014) Curr Oncol , vol.21 , pp. e129-e136
    • Karanicolas, P.J.1    Metrakos, P.2    Chan, K.3
  • 121
    • 70249149719 scopus 로고    scopus 로고
    • Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma
    • Kemeny NE, Melendez FD, Capanu M, et al. Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2009;27:3465-71.
    • (2009) J Clin Oncol , vol.27 , pp. 3465-3471
    • Kemeny, N.E.1    Melendez, F.D.2    Capanu, M.3
  • 122
    • 0028104996 scopus 로고
    • Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma
    • Kemeny N, Conti JA, Cohen A, et al. Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 1994;12:2288-95.
    • (1994) J Clin Oncol , vol.12 , pp. 2288-2295
    • Kemeny, N.1    Conti, J.A.2    Cohen, A.3
  • 123
    • 0026570019 scopus 로고
    • A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer
    • Kemeny N, Seiter K, Niedzwiecki D, et al. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 1992;69:327-34.
    • (1992) Cancer , vol.69 , pp. 327-334
    • Kemeny, N.1    Seiter, K.2    Niedzwiecki, D.3
  • 124
    • 77950864892 scopus 로고    scopus 로고
    • Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases
    • Goéré D, Deshaies I, de Baere T, et al. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases. Ann Surg 2010;251:686-91.
    • (2010) Ann Surg , vol.251 , pp. 686-691
    • Goéré, D.1    Deshaies, I.2    de Baere, T.3
  • 125
    • 84871596728 scopus 로고    scopus 로고
    • Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy
    • Goéré D, Benhaim L, Bonnet S, et al. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy. Ann Surg 2013;257:114-20.
    • (2013) Ann Surg , vol.257 , pp. 114-120
    • Goéré, D.1    Benhaim, L.2    Bonnet, S.3
  • 126
    • 20544466137 scopus 로고    scopus 로고
    • Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: An institutional experience of 544 consecutive cases
    • Allen PJ, Nissan A, Picon AI, et al. Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: An institutional experience of 544 consecutive cases. J Am Coll Surg 2005;201:57-65.
    • (2005) J Am Coll Surg , vol.201 , pp. 57-65
    • Allen, P.J.1    Nissan, A.2    Picon, A.I.3
  • 127
    • 33750722420 scopus 로고    scopus 로고
    • Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: Preliminary results
    • Aliberti C, Tilli M, Benea G, et al. Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: Preliminary results. Anticancer Res 2006;26:3793-5.
    • (2006) Anticancer Res , vol.26 , pp. 3793-3795
    • Aliberti, C.1    Tilli, M.2    Benea, G.3
  • 128
    • 84855170685 scopus 로고    scopus 로고
    • Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC bead(R), drug-eluting bead loaded with irinotecan: Results of a phase II clinical study
    • Aliberti C, Fiorentini G, Muzzio PC, et al. Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC bead(R), drug-eluting bead loaded with irinotecan: Results of a phase II clinical study. Anticancer Res 2011;31:4581-7.
    • (2011) Anticancer Res , vol.31 , pp. 4581-4587
    • Aliberti, C.1    Fiorentini, G.2    Muzzio, P.C.3
  • 129
    • 84859971752 scopus 로고    scopus 로고
    • Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: Final results of a phase III study
    • Fiorentini G, Aliberti C, Tilli M, et al. Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: Final results of a phase III study. Anticancer Res 2012;32:1387-95.
    • (2012) Anticancer Res , vol.32 , pp. 1387-1395
    • Fiorentini, G.1    Aliberti, C.2    Tilli, M.3
  • 130
    • 84874351924 scopus 로고    scopus 로고
    • Intra-arterial therapies for metastatic colorectal cancer
    • Wang DS, Louie JD, Sze DY. Intra-arterial therapies for metastatic colorectal cancer. Semin Intervent Radiol 2013;30:12-20.
    • (2013) Semin Intervent Radiol , vol.30 , pp. 12-20
    • Wang, D.S.1    Louie, J.D.2    Sze, D.Y.3
  • 131
    • 34147190131 scopus 로고    scopus 로고
    • Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy
    • quiz 562
    • Murthy R, Brown DB, Salem R, et al. Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy. J Vasc Interv Radiol 2007;18:553-61; quiz 562.
    • (2007) J Vasc Interv Radiol , vol.18 , pp. 553-561
    • Murthy, R.1    Brown, D.B.2    Salem, R.3
  • 132
    • 77955058493 scopus 로고    scopus 로고
    • Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases
    • Cosimelli M, Golfieri R, Cagol PP, et al. Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br J Cancer 2010;103:324-31.
    • (2010) Br J Cancer , vol.103 , pp. 324-331
    • Cosimelli, M.1    Golfieri, R.2    Cagol, P.P.3
  • 133
    • 71449084950 scopus 로고    scopus 로고
    • Selective internal radiation therapy with SIR-spheres for the treatment of unresectable colorectal hepatic metastases
    • Cianni R, Urigo C, Notarianni E, et al. Selective internal radiation therapy with SIR-spheres for the treatment of unresectable colorectal hepatic metastases. Cardiovasc Intervent Radiol 2009;32:1179-86.
    • (2009) Cardiovasc Intervent Radiol , vol.32 , pp. 1179-1186
    • Cianni, R.1    Urigo, C.2    Notarianni, E.3
  • 134
    • 48949115121 scopus 로고    scopus 로고
    • Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases
    • Jakobs TF, Hoffmann RT, Dehm K, et al. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. J Vasc Interv Radiol 2008;19:1187-95.
    • (2008) J Vasc Interv Radiol , vol.19 , pp. 1187-1195
    • Jakobs, T.F.1    Hoffmann, R.T.2    Dehm, K.3
  • 135
    • 33646237122 scopus 로고    scopus 로고
    • Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: Modern USA experience
    • Kennedy AS, Coldwell D, Nutting C, et al. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: Modern USA experience. Int J Radiat Oncol Biol Phys 2006;65:412-25.
    • (2006) Int J Radiat Oncol Biol Phys , vol.65 , pp. 412-425
    • Kennedy, A.S.1    Coldwell, D.2    Nutting, C.3
  • 136
    • 84858699403 scopus 로고    scopus 로고
    • Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experience
    • Nace GW, Steel JL, Amesur N, et al. Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experience. Int J Surg Oncol 2011;2011:571261.
    • (2011) Int J Surg Oncol , vol.2011 , pp. 571261
    • Nace, G.W.1    Steel, J.L.2    Amesur, N.3
  • 137
    • 84855352348 scopus 로고    scopus 로고
    • Radioembolization versus standard care of hepatic metastases: Comparative retrospective cohort study of survival outcomes and adverse events in salvage patients
    • Bester L, Meteling B, Pocock N, et al. Radioembolization versus standard care of hepatic metastases: Comparative retrospective cohort study of survival outcomes and adverse events in salvage patients. J Vasc Interv Radiol 2012;23:96-105.
    • (2012) J Vasc Interv Radiol , vol.23 , pp. 96-105
    • Bester, L.1    Meteling, B.2    Pocock, N.3
  • 138
    • 84892384969 scopus 로고    scopus 로고
    • Impact of stereotactic body radiotherapy on colorectal cancer with distant metastases
    • Hiraki M, Nishimura J, Ohtsuka M, et al. Impact of stereotactic body radiotherapy on colorectal cancer with distant metastases. Oncol Rep 2014;31:795-9.
    • (2014) Oncol Rep , vol.31 , pp. 795-799
    • Hiraki, M.1    Nishimura, J.2    Ohtsuka, M.3
  • 139
    • 63749100778 scopus 로고    scopus 로고
    • Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases
    • Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009;27:1572-8.
    • (2009) J Clin Oncol , vol.27 , pp. 1572-1578
    • Rusthoven, K.E.1    Kavanagh, B.D.2    Cardenes, H.3
  • 140
    • 76649108554 scopus 로고    scopus 로고
    • Stereotactic body radiation therapy for colorectal liver metastases
    • van der Pool AE, Mendez Romero A, Wunderink W, et al. Stereotactic body radiation therapy for colorectal liver metastases. Br J Surg 2010;97:377-82.
    • (2010) Br J Surg , vol.97 , pp. 377-382
    • van der Pool, A.E.1    Mendez Romero, A.2    Wunderink, W.3
  • 141
    • 80051923466 scopus 로고    scopus 로고
    • Stereotactic body radiotherapy for colorectal liver metastases: A pooled analysis
    • Chang DT, Swaminath A, Kozak M, et al. Stereotactic body radiotherapy for colorectal liver metastases: A pooled analysis. Cancer 2011;117:4060-9.
    • (2011) Cancer , vol.117 , pp. 4060-4069
    • Chang, D.T.1    Swaminath, A.2    Kozak, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.